While Carter continues to visit UAB for regular checkups, she has now been cancer-free for over three years. She uses her ...
A study volunteer receiving Intellia’s transthyretin amyloidosis treatment was hospitalized due to severe signs of liver ...
Experts at SCOPE Europe 2025 confronted the challenges posed by rapid trial proliferation, digital transformation and ...
In separate treatment trials, one for de novo coronary lesions and the other for in-stent restenosis, a sirolimus-eluting ...
| Clinical development is undergoing a structural shift. Protocols are growing more complex, budgets are shrinking, and ...
Taiwanese scientists have developed a natural fatty acid serum that triggers rapid hair regrowth by stimulating fat cells, ...
The Covid-19 shot may have further-reaching benefits than previously thought, as mRNA vaccines appear to help increase the ...
Daewoong Pharmaceutical (Co-CEOs Seong-Soo Park and Chang-Jae Lee) announced that its first-in-class idiopathic pulmonary ...
TipRanks on MSN
Amgen’s Avacopan Study: A Closer Look at Long-term Safety in ANCA-associated Vasculitis
Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. is conducting a Phase 4 clinical trial ...
The U.S. Food and Drug Administration has approved Lynkuet, a new medication that does not contain hormones to treat hot ...
TipRanks on MSN
Daiichi Sankyo’s Latest Clinical Trial: A Potential Game-Changer for Prostate Cancer Treatment
Daiichi Sankyo Company (($DSKYF)) announced an update on their ongoing clinical study. Study Overview: The clinical study titled ‘MK-2400-01A ...
Results demonstrated that similar outcomes can be achieved by a human coach-based program and an AI-based program. Moreover, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback